GSK Posts 340B Refund Notice on High-Revenue Asthma Treatment

GlaxoSmithKline wordmark and GSK logo on a building
Drugmaker GSK owes refunds to certain 340B providers for its asthma product Nucala, a notice posted to a government site said.
Drugmaker GlaxoSmithKline has posted another refund notice to 340B providers related to purchases of its high-earning asthma drugs. A Jan. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genesis Ruling Creates Legal, Regulatory Uncertainty for 340B, Says Attorney Panel

Maureen Testoni, president and CEO of 340B Health, Jason Reddish, a principal at Powers Law, and Ross Margulies, a partner at Foley Hoag, discussed the looming uncertainty in 340B following a key federal district court ruling during the 340B Coalition Winter Conference.
A recent federal district court ruling on the 340B patient definition created a “gray area” for 340B providers and drugmakers, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Tennessee Bills Introduced to Regulate 340B Funding for Certain STD Clinics

Companion bills recently introduced in the Tennessee state house and senate would add regulations for 340B in-kind funding.
Tennessee state lawmakers have introduced companion bills that would require sexually transmitted disease (STD) clinics to enter into a contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Former Sen. Cassidy Aide, Trump Administration Executive Criticizes Requiring More Hospital 340B Reporting

Brenda Destro, a former aide to a Republican senator and HHS official, recently wrote an op-ed that criticized hospital 340B transparency legislation.
A former Trump administration Health and Human Service Department (HHS) executive and adviser to Sen. Bill Cassidy (R-LA) published a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genesis Decision Expected to Increase 340B Scripts, Provider-Owned Pharmacies, Says Contractor to Drug Manufacturers and Former Apexus Staffer

Gavin Magaha, senior director of innovation at Kalderos and a former Apexus executive, said a recent judicial ruling on the 340B patient definition could increase the number of 340B patients and provider-owned pharmacies.
The ruling in a recent, high-profile 340B patient definition case will likely result in providers increasing the number of patients [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health Systems, HRSA Spar in Federal Court Over 340B Registration Policy Reversal

U.S. District Court of the District of Columbia
A hospital association asked the U.S. District Court of the District of Columbia to side with more than 40 health systems that sued federal regulators over a hospital registration policy change.
Forty-four health systems have asked a federal district court to decide, without a full trial, on their lawsuit against federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

GSK, Vertex Offer Refunds to 340B Providers

GSK headquarters
GSK was one of two drugmakers to issue refunds to 340B covered entities, according to notices posted on a government regulatory site.
Drugmakers GlaxoSmithKline and Vertex Pharmaceuticals will offer refunds to 340B providers related to the purchases of several of their high-earning [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HIV/AIDS Group Continues Legal Fight with Apexus Over 340B Prime Vendor Contract

AHF has asked a federal appeals court to reverse an earlier court's decision to dismiss a case against Apexus over its provision of 340B sub-ceiling price discounts on drugs.
The AIDS Healthcare Foundation (AHF) recently urged a federal appeals court to reverse a lower court’s decision to dismiss its [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New Medicaid Policy Change Could Reduce 340B Savings, Cause Drug Discontinuations, Warn Stakeholders

A Medicaid drug rebate policy change that recently took effect could lead to reduced 340B savings and drug discontinuations.
A Medicaid policy change that took effect at the start of 2024 could indirectly lead to lower 340B savings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

$7.8 Billion in Refunds from Underpayments to 340B Hospitals Begin to Roll In

A map of Medicare administrative contractors' (MAC's) jurisdictions. MACs in more than half the states have begun to issue refunds to 340B hospitals for unlawful Medicare cuts from 2018-2022.
Medicare administrative contractors (MACs) covering more than half the states have initiated lump sum repayments to 340B hospitals, after getting [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report